Needham Reiterates Hold Rating on Teladoc (TDOC)

Needham analyst Ryan MacDonald reiterated a Hold rating on Teladoc (NYSE: TDOC).

The analyst commented: "We reiterate our Hold rating on Teladoc (TDOC) following the company's 2Q25 earnings results. While TDOC produced a top- and bottom-line beat in 2Q, this success was not passed through to the updated FY25 outlook. BetterHelp appears to be the primary driver of this decline as the business continues to be impacted by increased competition for vendors offering insurance covered care relative to BH's cash pay business. While TDOC is working to remedy this situation via the acquisition of Uplift, the scaling of insurance presents execution risk, in our view, as TDOC remains in the early innings of getting BH therapists to sign-up for the insurance option, while lower margins associated with insurance reimbursement could limit margin expansion opportunities. We remain on the sidelines until a clearer picture of fundamental upside can be seen."

For an analyst ratings summary and ratings history on Teladoc click here. For more ratings news on Teladoc click here.

Shares of Teladoc closed at $7.53 yesterday.

You May Also Be Interested In

• Invesco Mortgage Capital declares $0.12 monthly dividend for June 2026
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• MicroVision applies to transfer listing to NASDAQ capital market